Brief: Irras Receives FDA Clearance For IRRAflow Control Unit
12/12/2022 08:12
Dec 12 (Reuters) - Irras AB IRRAS.ST :
* IRRAS RECEIVES US FDA 510(K) CLEARANCE FOR ITS NEXT
GENERATION
IRRAFLOW CONTROL UNIT
* RECEIVES REGULATORY CLEARANCE FROM FDA TO ACTIVE ALL OF
FUNCTIONALITY ON NEXT GENERATION CONTROL UNIT FOR CO'S FLAGSHIP
PRODUCT, IRRAFLOW
Source text for Eikon: ID:nWkr7gFy3d
Further company coverage: IRRAS.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Irras AB
See all newsBrief: Irras's Says Application For Delisting Has Been Approved
Brief: IR Holding Bidco Says It Requests Compulsory Buy-Out And IRRAS Applies For Delisting
Brief: Irras Extends Maturity Date Of SEK 20 Mln Loan
Brief: Irras Secures Extended Short-Term Loan Agreement
Brief: Irras Sees Risk Of Becoming Insolvent